The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells

Mohamed Bilal Fares, Nadine Ait-Bouziad, Igor Dikiy, Martial K. Mbefo, Ana Jovičić, Aoife Kiely, Janice L. Holton, Seung Jae Lee, Aaron D. Gitler, David Eliezer, Hilal A. Lashuel

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

A novel mutation in the α-Synuclein (α-Syn) gene "G51D" was recently identified in two familial cases exhibiting features of Parkinson's disease (PD) and multiple system atrophy (MSA). In this study,we explored the impact of this novel mutation on the aggregation, cellular and biophysical properties of α-Syn, in an attempt to unravel how this mutant contributes to PD/MSA. Our results show that the G51D mutation significantly attenuates α-Syn aggregation in vitro. Moreover, it disrupts local helix formation in the presence of SDS, decreases binding to lipid vesicles C-terminal to the site of mutation and severely inhibits helical folding in the presence of acidic vesicles. When expressed in yeast, α-SynG51D behaves similarly to α-SynA30P, as both exhibit impaired membrane association, form few inclusions and are non-toxic. In contrast, enhanced secreted and nuclear levels of the G51D mutant were observed in mammalian cells, as well as in primary neurons, where α-SynG51D was enriched in the nuclear compartment, was hyper-phosphorylated at S129 and exacerbated α-Syn-induced mitochondrial fragmentation. Finally, post-mortem human brain tissues of α-SynG51D cases were examined, and revealed only partial colocalization with nuclear membrane markers, probably due to post-mortem tissue delay and fixation. These findings suggest that the PD-linked mutations may cause neurodegeneration via different mechanisms, some of which may be independent of α-Syn aggregation.

Original languageEnglish
Article numberddu165
Pages (from-to)4491-4509
Number of pages19
JournalHuman Molecular Genetics
Volume23
Issue number17
DOIs
Publication statusPublished - 1 Jan 2014
Externally publishedYes

Fingerprint

Synucleins
Parkinson Disease
Mutation
Membranes
Multiple System Atrophy
Tissue Fixation
Nuclear Envelope
Yeasts
In Vitro Techniques
Lipids
Neurons
Brain
Genes

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells. / Fares, Mohamed Bilal; Ait-Bouziad, Nadine; Dikiy, Igor; Mbefo, Martial K.; Jovičić, Ana; Kiely, Aoife; Holton, Janice L.; Lee, Seung Jae; Gitler, Aaron D.; Eliezer, David; Lashuel, Hilal A.

In: Human Molecular Genetics, Vol. 23, No. 17, ddu165, 01.01.2014, p. 4491-4509.

Research output: Contribution to journalArticle

Fares, MB, Ait-Bouziad, N, Dikiy, I, Mbefo, MK, Jovičić, A, Kiely, A, Holton, JL, Lee, SJ, Gitler, AD, Eliezer, D & Lashuel, HA 2014, 'The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells', Human Molecular Genetics, vol. 23, no. 17, ddu165, pp. 4491-4509. https://doi.org/10.1093/hmg/ddu165
Fares, Mohamed Bilal ; Ait-Bouziad, Nadine ; Dikiy, Igor ; Mbefo, Martial K. ; Jovičić, Ana ; Kiely, Aoife ; Holton, Janice L. ; Lee, Seung Jae ; Gitler, Aaron D. ; Eliezer, David ; Lashuel, Hilal A. / The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells. In: Human Molecular Genetics. 2014 ; Vol. 23, No. 17. pp. 4491-4509.
@article{a4c0cd9943834eb1b3fe908f56679d62,
title = "The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells",
abstract = "A novel mutation in the α-Synuclein (α-Syn) gene {"}G51D{"} was recently identified in two familial cases exhibiting features of Parkinson's disease (PD) and multiple system atrophy (MSA). In this study,we explored the impact of this novel mutation on the aggregation, cellular and biophysical properties of α-Syn, in an attempt to unravel how this mutant contributes to PD/MSA. Our results show that the G51D mutation significantly attenuates α-Syn aggregation in vitro. Moreover, it disrupts local helix formation in the presence of SDS, decreases binding to lipid vesicles C-terminal to the site of mutation and severely inhibits helical folding in the presence of acidic vesicles. When expressed in yeast, α-SynG51D behaves similarly to α-SynA30P, as both exhibit impaired membrane association, form few inclusions and are non-toxic. In contrast, enhanced secreted and nuclear levels of the G51D mutant were observed in mammalian cells, as well as in primary neurons, where α-SynG51D was enriched in the nuclear compartment, was hyper-phosphorylated at S129 and exacerbated α-Syn-induced mitochondrial fragmentation. Finally, post-mortem human brain tissues of α-SynG51D cases were examined, and revealed only partial colocalization with nuclear membrane markers, probably due to post-mortem tissue delay and fixation. These findings suggest that the PD-linked mutations may cause neurodegeneration via different mechanisms, some of which may be independent of α-Syn aggregation.",
author = "Fares, {Mohamed Bilal} and Nadine Ait-Bouziad and Igor Dikiy and Mbefo, {Martial K.} and Ana Jovičić and Aoife Kiely and Holton, {Janice L.} and Lee, {Seung Jae} and Gitler, {Aaron D.} and David Eliezer and Lashuel, {Hilal A.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1093/hmg/ddu165",
language = "English",
volume = "23",
pages = "4491--4509",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "17",

}

TY - JOUR

T1 - The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells

AU - Fares, Mohamed Bilal

AU - Ait-Bouziad, Nadine

AU - Dikiy, Igor

AU - Mbefo, Martial K.

AU - Jovičić, Ana

AU - Kiely, Aoife

AU - Holton, Janice L.

AU - Lee, Seung Jae

AU - Gitler, Aaron D.

AU - Eliezer, David

AU - Lashuel, Hilal A.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - A novel mutation in the α-Synuclein (α-Syn) gene "G51D" was recently identified in two familial cases exhibiting features of Parkinson's disease (PD) and multiple system atrophy (MSA). In this study,we explored the impact of this novel mutation on the aggregation, cellular and biophysical properties of α-Syn, in an attempt to unravel how this mutant contributes to PD/MSA. Our results show that the G51D mutation significantly attenuates α-Syn aggregation in vitro. Moreover, it disrupts local helix formation in the presence of SDS, decreases binding to lipid vesicles C-terminal to the site of mutation and severely inhibits helical folding in the presence of acidic vesicles. When expressed in yeast, α-SynG51D behaves similarly to α-SynA30P, as both exhibit impaired membrane association, form few inclusions and are non-toxic. In contrast, enhanced secreted and nuclear levels of the G51D mutant were observed in mammalian cells, as well as in primary neurons, where α-SynG51D was enriched in the nuclear compartment, was hyper-phosphorylated at S129 and exacerbated α-Syn-induced mitochondrial fragmentation. Finally, post-mortem human brain tissues of α-SynG51D cases were examined, and revealed only partial colocalization with nuclear membrane markers, probably due to post-mortem tissue delay and fixation. These findings suggest that the PD-linked mutations may cause neurodegeneration via different mechanisms, some of which may be independent of α-Syn aggregation.

AB - A novel mutation in the α-Synuclein (α-Syn) gene "G51D" was recently identified in two familial cases exhibiting features of Parkinson's disease (PD) and multiple system atrophy (MSA). In this study,we explored the impact of this novel mutation on the aggregation, cellular and biophysical properties of α-Syn, in an attempt to unravel how this mutant contributes to PD/MSA. Our results show that the G51D mutation significantly attenuates α-Syn aggregation in vitro. Moreover, it disrupts local helix formation in the presence of SDS, decreases binding to lipid vesicles C-terminal to the site of mutation and severely inhibits helical folding in the presence of acidic vesicles. When expressed in yeast, α-SynG51D behaves similarly to α-SynA30P, as both exhibit impaired membrane association, form few inclusions and are non-toxic. In contrast, enhanced secreted and nuclear levels of the G51D mutant were observed in mammalian cells, as well as in primary neurons, where α-SynG51D was enriched in the nuclear compartment, was hyper-phosphorylated at S129 and exacerbated α-Syn-induced mitochondrial fragmentation. Finally, post-mortem human brain tissues of α-SynG51D cases were examined, and revealed only partial colocalization with nuclear membrane markers, probably due to post-mortem tissue delay and fixation. These findings suggest that the PD-linked mutations may cause neurodegeneration via different mechanisms, some of which may be independent of α-Syn aggregation.

UR - http://www.scopus.com/inward/record.url?scp=84901338303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901338303&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddu165

DO - 10.1093/hmg/ddu165

M3 - Article

VL - 23

SP - 4491

EP - 4509

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 17

M1 - ddu165

ER -